# Aesculap Inc – FDA Inspection, Jun 13, 2018

Source: https://www.keypedia.com/records/fda_inspections/aesculap-inc/c9f80ead-069e-45e5-89ad-16f17bab6bf2
Source feed: FDA_Inspections

> FDA inspection 1055539 of Aesculap Inc, June 13, 2018. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1055539
- Company Name: Aesculap Inc
- Inspection Date: 2018-06-13
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 986649 - 2016-09-14
- FDA Inspection 901818 - 2014-10-23
- FDA Inspection 843597 - 2013-08-09
- FDA Inspection 675706 - 2010-07-13

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/kathleen-b-swat/8bbaa25d-cf50-4da5-8b6c-ce32df24e978)
- Issuing Officer

Company: https://www.keypedia.com/companies/aesculap-inc/40479973-1b19-440a-8e8c-5aeec6c45a29

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
